Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis

By sjmartinez • April 12, 2025

Gunes I, Bernstein EJ, Cowper SE, Panse G, Pradhan N, Camacho LD, Page N, Bundschuh E, Williams A, Carns M, Aren K, Fantus S, Volkmann ER, Bukiri H, Correia C, Kolachalama VB, Wilson FP, Mawe S, Mahoney JM, Hinchcliff M. Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis. Arthritis Res Ther. 2025 Apr 11;27(1):85. doi: 10.1186/s13075-025-03508-9. PMID: 40217251; PMCID: PMC11987334.

Tags: AlexNet, Artificial intelligence, Belumosudil, Deep Neural Network, Dermal fibrosis, Modified Rodnan skin score, outcome measure, Outcomes, Publications, Rheumatology, Scleroderma, Skin fibrosis, systemic sclerosis

Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy

Li YR, Nan H, Liu Z, Fang Y, Zhu Y, Lyu Z, Shao Z, Zhu E, Zhang B, Yang Y, Shen X, Chen Y, Hsiai[...]

JPEN Journal Club 99. ICEMAN analyses

Koretz RL. JPEN Journal Club 99. ICEMAN analyses. JPEN J Parenter Enteral Nutr. 2026 Mar 17. doi: 10.1002/jpen.70072. Epub ahead of print. PMID: 41846318.

A Double-blind Randomized Trial of Oral Chlorhexidine Gluconate for Treatment of Oral Staphylococcus aureus Colonization in Healthy Children

Liu L, Launer B, Flores E, Tchakalian G, Kreiswirth B, Bolaris M, Kim T, Young KD, Miller LG. A Double-blind Randomized Trial of Oral Chlorhexidine[...]